[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-04", "acceptance_datetime": "2025-11-04T21:02:57Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-25-048785", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-25-048785/files/bcrx-20250930_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": -506000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 12393000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": 12393000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": 12393000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": 12899000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": 12899000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "gross_profit": {"value": 157208000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "operating_expenses": {"value": 127617000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit": {"value": -769000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_average_shares": {"value": 219885000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": 12899000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 44603000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 159395000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": 12899000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_earnings_per_share": {"value": 0.06, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "benefits_costs_expenses": {"value": 147265000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "cost_of_revenue": {"value": 2187000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_income_loss": {"value": 29591000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "selling_general_and_administrative_expenses": {"value": 83014000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "basic_earnings_per_share": {"value": 0.06, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": -17461000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 129804000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": 12130000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 210176000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "cash_flow_statement": {"net_cash_flow": {"value": -4086000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": 41624000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 13572000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 13572000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -3618000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "exchange_gains_losses": {"value": -468000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": 41624000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -58814000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -58814000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"accounts_payable": {"value": 5567000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 644076000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 446424000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 90740000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -387889000.0, "unit": "USD", "label": "Equity", "order": 1400}, "inventory": {"value": 5232000.0, "unit": "USD", "label": "Inventory", "order": 230}, "fixed_assets": {"value": 8396000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 82344000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 834313000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 350452000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 355684000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 190237000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 446424000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 184670000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": -387889000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-05", "acceptance_datetime": "2025-08-05T20:03:30Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-25-037795", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-25-037795/files/bcrx-20250630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 29127000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -1898000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "exchange_gains_losses": {"value": 1359000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": 41302000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -73686000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -73686000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 29127000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -3257000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": 41302000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"income_tax_expense_benefit": {"value": 1401000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": 5085000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": 0.02, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "selling_general_and_administrative_expenses": {"value": 87383000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "basic_average_shares": {"value": 209519000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": 0.02, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": 6486000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": 5085000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 156867000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 130769000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "cost_of_revenue": {"value": 2798000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_income_loss": {"value": 29786000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_average_shares": {"value": 219886000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "nonoperating_income_loss": {"value": -23300000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": 5085000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 133567000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "gross_profit": {"value": 160555000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "revenues": {"value": 163353000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": 5085000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 43386000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "balance_sheet": {"noncurrent_assets": {"value": 58726000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 457188000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 878782000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 398462000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 8457000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 168571000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 8589000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 177160000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 457188000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": -421594000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "inventory": {"value": 5044000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_assets": {"value": 393418000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": -421594000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 50269000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "comprehensive_income": {"comprehensive_income_loss": {"value": 5085000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": 5599000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 514000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-06", "acceptance_datetime": "2025-05-06T20:03:08Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-25-022658", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-25-022658/files/bcrx-20250331_htm.xml", "financials": {"balance_sheet": {"inventory": {"value": 6873000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_liabilities": {"value": 129806000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 10049000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 931974000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 62477000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 409977000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 139855000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 480047000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 70070000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 480047000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -451927000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 7593000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 403104000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_parent": {"value": -451927000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 107000, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 27095000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 529000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -27517000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 558000, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 529000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -27517000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 27095000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": 451000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": 32000, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 211000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_parent": {"value": 243000, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"gross_profit": {"value": 140966000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_attributable_to_parent": {"value": 32000, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": 0, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 145534000.0, "unit": "USD", "label": "Revenues", "order": 100}, "cost_of_revenue": {"value": 4568000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_available_to_common_stockholders_basic": {"value": 32000, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 124307000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 215261000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_tax_expense_benefit": {"value": 726000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": 32000, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 37270000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 144776000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_earnings_per_share": {"value": 0, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": 21227000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": 758000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 119739000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 208882000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "selling_general_and_administrative_expenses": {"value": 82469000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss": {"value": 32000, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "nonoperating_income_loss": {"value": -20469000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -5213000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 17797000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": -4021000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 8563000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": -4021000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "exchange_gains_losses": {"value": -1304000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities_continuing": {"value": -5213000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 7259000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 17797000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"income_tax_expense_benefit": {"value": 804000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "research_and_development": {"value": 49441000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "cost_of_revenue": {"value": 6094000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "costs_and_expenses": {"value": 136042000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -26795000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 157525000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_average_shares": {"value": 230000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": -25991000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -4508000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 37000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "selling_general_and_administrative_expenses": {"value": 80470000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_expenses": {"value": 129948000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -26795000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 230000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.13, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -26795000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.13, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "gross_profit": {"value": 125440000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 131534000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -26795000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -28167000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -28167000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -28167000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"fixed_assets": {"value": 7777000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 68452000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": -475934000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 60675000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": -475934000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 160384000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "inventory": {"value": 31274000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_liabilities": {"value": 100109000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 48631000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 805970000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 421968000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 490420000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 390694000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 11644000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 966354000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 490420000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-05", "acceptance_datetime": "2024-11-05T22:19:10Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-24-045364", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-24-045364/files/bcrx-20240930_htm.xml", "financials": {"balance_sheet": {"accounts_payable": {"value": 13482000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 64129000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": -468563000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "inventory": {"value": 7562000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 959817000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 140085000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 7421000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 491254000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_receivable": {"value": 1000000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_liabilities": {"value": 153567000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 418563000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 491254000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 806250000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 56708000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": -468563000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 427125000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": 1736000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -12297000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -12297000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -12297000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"exchange_gains_losses": {"value": 851000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities_continuing": {"value": 1274000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 8489000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": 8245000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 18859000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 8489000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 18008000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 1274000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": 8245000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"costs_and_expenses": {"value": 109393000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -14033000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "selling_general_and_administrative_expenses": {"value": 65084000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 106182000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 206905000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": -13447000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": 7692000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.07, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "cost_of_revenue": {"value": 3211000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "benefits_costs_expenses": {"value": 130532000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 206905000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 41081000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.07, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -14033000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "gross_profit": {"value": 113874000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_tax_expense_benefit": {"value": 586000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 117085000.0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 17000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14033000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -14033000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-06", "acceptance_datetime": "2024-08-06T20:04:28Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-24-035170", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-24-035170/files/bcrx-20240630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -1368000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -1368000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -1966000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -5926000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "exchange_gains_losses": {"value": -143000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": -5783000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -2449000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -2449000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -1966000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -12888000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -12674000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -214000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"current_assets": {"value": 363457000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 472419000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_receivable": {"value": 2119000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "accounts_payable": {"value": 7786000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 475606000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 101299000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 472419000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 108962000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 7663000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": -475606000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_assets": {"value": 356888000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_current_liabilities": {"value": 121279000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "inventory": {"value": 4450000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity_attributable_to_parent": {"value": -475606000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 129065000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -12502000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 109332000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -12674000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 35000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -12674000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 206425000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "costs_and_expenses": {"value": 100571000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 24733000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "basic_average_shares": {"value": 206425000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 172000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12674000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 121834000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 98872000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.06, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 37623000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "selling_general_and_administrative_expenses": {"value": 61214000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_parent": {"value": -12674000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "gross_profit": {"value": 107633000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "cost_of_revenue": {"value": 1699000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "basic_earnings_per_share": {"value": -0.06, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": 8761000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-07", "acceptance_datetime": "2024-05-07T20:02:30Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-24-021069", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-24-021069/files/bcrx-20240331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -566000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -35379000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -566000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -35945000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"inventory": {"value": 29781000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_assets": {"value": 413741000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_parent": {"value": -476167000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 11910000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "accounts_receivable": {"value": 3578000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "equity": {"value": -476167000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 20792000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 12961000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 467892000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 119921000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 447100000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 476167000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 108011000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 467892000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 7831000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_after_tax": {"value": -35379000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 365000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "selling_general_and_administrative_expenses": {"value": 59364000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_parent": {"value": -35379000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "gross_profit": {"value": 91496000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "revenues": {"value": 92761000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 206064000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -14488000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 105984000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 46493000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -35379000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_expense_operating": {"value": 24506000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": -35379000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 127000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "costs_and_expenses": {"value": 107249000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "cost_of_revenue": {"value": 1265000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "benefits_costs_expenses": {"value": 127775000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -35014000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 206064000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "cash_flow_statement": {"exchange_gains_losses": {"value": -340000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": -1048000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -25976000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 28756000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -26316000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -53684000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": -1048000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -53684000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 28756000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "financials": {"income_statement": {"income_tax_expense_benefit": {"value": -1431000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "basic_earnings_per_share": {"value": -0.30999999999999994, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 93401000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -61731000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.30999999999999994, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "interest_expense_operating": {"value": 24583000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "diluted_average_shares": {"value": 3103000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 134514000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 3103000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 80000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "costs_and_expenses": {"value": 136071000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -61731000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -61731000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -42670000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "selling_general_and_administrative_expenses": {"value": 64382000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 70052000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "cost_of_revenue": {"value": 1557000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "benefits_costs_expenses": {"value": 156563000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -61731000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "gross_profit": {"value": 91844000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -63162000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "balance_sheet": {"wages": {"value": 36518000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 20893000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 92577000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": -455528000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -455528000.0, "unit": "USD", "label": "Equity", "order": 1400}, "inventory": {"value": 28683000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 972488000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 464987000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 495966000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 822500000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 13084000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 516960000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 149988000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_receivable": {"value": 2296000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 516960000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 20994000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 7910000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 165345000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -61194000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -61194000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow": {"value": -40042000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -40564000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -28473000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": -3173000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -8918000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -8918000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -28473000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -3173000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "exchange_gains_losses": {"value": 522000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-08", "acceptance_datetime": "2023-11-08T21:12:06Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-23-037847", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-23-037847/files/bcrx-20230930_htm.xml", "financials": {"income_statement": {"benefits_costs_expenses": {"value": 122561000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -11921000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -36149000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 27345000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "other_operating_expenses": {"value": 37000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -36149000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "selling_general_and_administrative_expenses": {"value": 50648000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": 189644000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 46879000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 189644000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 97564000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 86742000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "cost_of_revenue": {"value": 1099000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "costs_and_expenses": {"value": 98663000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -36149000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": 330000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -36149000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -35819000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "gross_profit": {"value": 85643000.0, "unit": "USD", "label": "Gross Profit", "order": 800}}, "cash_flow_statement": {"net_cash_flow": {"value": 4700000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -19897000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 23119000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": 253000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 1225000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 23119000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 1225000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 4447000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -19897000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"accounts_payable": {"value": 10567000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 8999000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 90763000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 522924000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 522924000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 933910000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": -410986000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_receivable": {"value": 1677000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_noncurrent_assets": {"value": 11459000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 20458000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 502466000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 80196000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": -410986000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 843147000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "inventory": {"value": 29630000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_assets": {"value": 471159000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 110000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -36039000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -36039000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-07", "acceptance_datetime": "2023-08-07T20:55:43Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-23-027820", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-23-027820/files/bcrx-20230630_htm.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -75326000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.4, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "research_and_development": {"value": 51247000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -74586000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "selling_general_and_administrative_expenses": {"value": 50997000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_income_loss": {"value": -20703000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 56000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -75326000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "gross_profit": {"value": 81597000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "cost_of_revenue": {"value": 894000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "basic_average_shares": {"value": 189118000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -0.4, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 82491000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -75326000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 103194000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 102300000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 157077000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 189118000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": 740000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "interest_expense_operating": {"value": 28915000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_parent": {"value": -75326000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "balance_sheet": {"inventory": {"value": 27033000.0, "unit": "USD", "label": "Inventory", "order": 230}, "fixed_assets": {"value": 8438000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 79609000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 13889000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": -388713000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 529885000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 511056000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 93498000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 481952000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities": {"value": 388713000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 529885000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_receivable": {"value": 2071000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_noncurrent_assets": {"value": 10391000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 18829000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": -388713000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -75221000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -75221000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 105000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -8493000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -18814000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 29356000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 29356000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -19035000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -8810000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "exchange_gains_losses": {"value": -317000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities_continuing": {"value": -18814000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -19035000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-08", "acceptance_datetime": "2023-05-08T20:37:44Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-23-016458", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-23-016458/files/bcrx-20230331_htm.xml", "financials": {"income_statement": {"basic_average_shares": {"value": 188509000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -53333000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -53333000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 96262000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -28415000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_average_shares": {"value": 188509000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 48388000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -53333000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "gross_profit": {"value": 67847000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "interest_expense_operating": {"value": 27396000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "selling_general_and_administrative_expenses": {"value": 47867000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "revenues": {"value": 68778000.0, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 97193000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 7000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -53333000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -52662000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_tax_expense_benefit": {"value": 671000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "benefits_costs_expenses": {"value": 121440000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "cost_of_revenue": {"value": 931000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}}, "balance_sheet": {"equity": {"value": -328287000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 490883000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 8376000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 509737000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 10478000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 18854000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": -328287000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 78903000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 85157000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 328287000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "inventory": {"value": 27466000.0, "unit": "USD", "label": "Inventory", "order": 230}, "accounts_payable": {"value": 6254000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 462326000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_receivable": {"value": 1091000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "liabilities_and_equity": {"value": 509737000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 5077000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -107109000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -47512000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -47512000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -149640000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -149544000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 5077000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -107109000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -96000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -52774000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -52774000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 559000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 77215000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 57896000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 4199000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 4199000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 77215000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -23849000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 57565000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -23849000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": 331000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}, "balance_sheet": {"liabilities": {"value": 844597000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 8617000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 550000000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_receivable": {"value": 8268000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "liabilities_and_equity": {"value": 550000000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 24883000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 516500000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 739083000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 105514000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": -294597000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "inventory": {"value": 27533000.0, "unit": "USD", "label": "Inventory", "order": 230}, "noncurrent_assets": {"value": 33500000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 14356000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 69033000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 22125000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity": {"value": -294597000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_assets": {"value": 480699000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -71417000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 175699000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -71417000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 123473000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 113000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": 76000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -71541000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 342000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -71541000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -71465000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.3800000000000001, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "cost_of_revenue": {"value": 2383000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "basic_average_shares": {"value": 342000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "interest_expense_operating": {"value": 26458000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "research_and_development": {"value": 73207000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 151010000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -46311000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -71541000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 125856000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -71541000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 79545000.0, "unit": "USD", "label": "Revenues", "order": 100}, "gross_profit": {"value": 77162000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "basic_earnings_per_share": {"value": -0.3800000000000001, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "selling_general_and_administrative_expenses": {"value": 50153000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-04", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-22-028463", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-22-028463/files/bcrx-20220930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -113000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -42633000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -42633000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 76325000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -69543000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -14000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": -25662000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -32444000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -69543000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -32444000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -25676000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 76325000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"assets": {"value": 558594000.0, "unit": "USD", "label": "Assets", "order": 100}, "inventory": {"value": 27019000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 801253000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 8622000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": -242659000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_assets": {"value": 478965000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_liabilities": {"value": 719616000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 558594000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 73015000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 41129000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 81637000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 49593000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_receivable": {"value": 3017000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "equity_attributable_to_parent": {"value": -242659000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 8464000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 509001000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.23, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "gross_profit": {"value": 72284000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "benefits_costs_expenses": {"value": 116825000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_tax_expense_benefit": {"value": 1522000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_income_loss": {"value": -17445000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "selling_general_and_administrative_expenses": {"value": 36919000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "basic_earnings_per_share": {"value": -0.23, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -42520000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 52740000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 70000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -42520000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 186180000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 186180000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -42520000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "costs_and_expenses": {"value": 93272000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -40998000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "cost_of_revenue": {"value": 3543000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_loss_from_continuing_operations_after_tax": {"value": -42520000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_expense_operating": {"value": 24775000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 75827000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 89729000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-05", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001628280-22-021373", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001628280-22-021373/files/bcrx-20220630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": -125048000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 147000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": 209000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -27757000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -124839000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -27757000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 147000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -97438000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -97438000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -171000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -59030000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -59030000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"diluted_average_shares": {"value": 185605000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -58859000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "cost_of_revenue": {"value": 246000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "other_operating_expenses": {"value": 1000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "gross_profit": {"value": 65286000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "selling_general_and_administrative_expenses": {"value": 38017000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -58859000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 856000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 100008000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 100254000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 61990000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -58859000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 123535000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_after_tax": {"value": -58859000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -34722000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 65532000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -58003000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 185605000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "interest_expense_operating": {"value": 24022000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"current_assets": {"value": 494853000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_assets": {"value": 469632000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": -213232000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": -213232000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 6983000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_receivable": {"value": 1843000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_liabilities": {"value": 95390000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 510538000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 8702000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "inventory": {"value": 23378000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_liabilities": {"value": 83366000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 12024000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 510538000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 15685000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 213232000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-09", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-22-003423", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-22-003423/files/bcrx20220331_10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -74187000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 9000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -74187000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.39999999999999997, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -74196000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "selling_general_and_administrative_expenses": {"value": 34282000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "income_loss_from_continuing_operations_before_tax": {"value": -73917000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": 184898000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "cost_of_revenue": {"value": 236000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss": {"value": -74196000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -74196000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_expense_operating": {"value": 23837000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "costs_and_expenses": {"value": 99880000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 99644000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -74196000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 279000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "basic_earnings_per_share": {"value": -0.4, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "benefits_costs_expenses": {"value": 123840000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "gross_profit": {"value": 49687000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "other_operating_expenses": {"value": 2000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -49957000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 49923000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 65360000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": -352000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "balance_sheet": {"other_current_liabilities": {"value": 67136000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 81017000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "inventory": {"value": 16144000.0, "unit": "USD", "label": "Inventory", "order": 230}, "fixed_assets": {"value": 8799000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 7207000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 13881000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 164215000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 511714000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 527720000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 493638000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_parent": {"value": -164215000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -164215000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 16006000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_receivable": {"value": 1932000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "assets": {"value": 527720000.0, "unit": "USD", "label": "Assets", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 7356000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "exchange_gains_losses": {"value": 40000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -77800000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -108916000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -38472000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 7356000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -77800000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -108876000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -38472000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "financials": {"cash_flow_statement": {"exchange_gains_losses": {"value": 2000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": -11120000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 303839000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 347418000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -11120000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -32459000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 303841000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -32459000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 347418000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 99335000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -17779000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 178938801.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "interest_expense_operating": {"value": 18780000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_available_to_common_stockholders_basic": {"value": -17779000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 103424000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "selling_general_and_administrative_expenses": {"value": 35387000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_expenses": {"value": 98917000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "gross_profit": {"value": 46740000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss": {"value": -17779000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 1000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -17779000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "cost_of_revenue": {"value": 418000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -52177000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 63529000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 47158000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -56266000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -17716000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -17716000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 166346000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"wages": {"value": 20674000.0, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 8714000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 548365000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_liabilities": {"value": 293277000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "long_term_debt": {"value": 298142000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_receivable": {"value": 1980000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "assets": {"value": 588151000.0, "unit": "USD", "label": "Assets", "order": 100}, "inventory": {"value": 15791000.0, "unit": "USD", "label": "Inventory", "order": 230}, "current_assets": {"value": 566136000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 588151000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 55236000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": -106986000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 695137000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 22015000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 103718000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 591419000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 27808000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 13301000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": -106986000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-04", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-21-007570", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-21-007570/files/bcrx20210930_10q_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 27000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -58774000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -58774000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -147044000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 252743000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 5191000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 7829000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 13020000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 113915000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 265763000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_receivable": {"value": 3286000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "accounts_payable": {"value": 19693000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 235794000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities": {"value": 412807000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 133608000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 279199000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 265763000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "inventory": {"value": 13663000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity_attributable_to_parent": {"value": -147044000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "income_statement": {"benefits_costs_expenses": {"value": 85578000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 84987000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "interest_expense_operating": {"value": 14115000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -44584000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 24000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -58801000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 85578000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -58801000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -58801000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "selling_general_and_administrative_expenses": {"value": 34992000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_average_shares": {"value": 179106, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 49971000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -58801000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "gross_profit": {"value": 40403000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "cost_of_revenue": {"value": 591000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_income_loss": {"value": -44584000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 40994000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -23276000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -10769000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 4776000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -10753000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 4776000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -23276000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 7747000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 7747000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": -16000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-09", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-21-005674", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-21-005674/files/bcrx20210630_10q_htm.xml", "financials": {"income_statement": {"costs_and_expenses": {"value": 79541000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 178127, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -43198000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "interest_expense_operating": {"value": 13495000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 52873000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "selling_general_and_administrative_expenses": {"value": 26325000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_income_loss": {"value": -29582000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -43198000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -43198000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 49959000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -43198000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -43198000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 46000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 79541000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "gross_profit": {"value": 49662000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "operating_expenses": {"value": 79244000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "cost_of_revenue": {"value": 297000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -95000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -43293000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -43293000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 4504000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -25411000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -16333000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -25411000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 4574000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 4504000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -16248000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 4574000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"accounts_payable": {"value": 10087000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 265802000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_assets": {"value": 249443000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 3813000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 7669000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": -106075000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_receivable": {"value": 6513000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_current_liabilities": {"value": 105514000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 11482000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 277284000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 106075000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -106075000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 277284000.0, "unit": "USD", "label": "Assets", "order": 100}, "inventory": {"value": 9846000.0, "unit": "USD", "label": "Inventory", "order": 230}, "current_liabilities": {"value": 115601000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-07", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-21-003310", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-21-003310/files/bcrx20210331_10q_htm.xml", "financials": {"income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -64284000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -64284000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -64284000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "selling_general_and_administrative_expenses": {"value": 22114000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -64284000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 42435000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 177343000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -64284000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "cost_of_revenue": {"value": 5923000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "costs_and_expenses": {"value": 70436000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": -36000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -51377000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 70436000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "revenues": {"value": 19059000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 64513000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "interest_expense_operating": {"value": 12904000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "gross_profit": {"value": 13136000.0, "unit": "USD", "label": "Gross Profit", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -64105000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 179000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -64105000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"equity_attributable_to_parent": {"value": -74988000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 284431000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 273771000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_receivable": {"value": 8504000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "noncurrent_assets": {"value": 10660000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 284431000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 3625000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 101201000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 7035000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 74988000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "inventory": {"value": 5113000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_liabilities": {"value": 87672000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -74988000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_assets": {"value": 260154000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 13529000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 2900000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 2900000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -43438000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 14673000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -61011000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -61011000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -43438000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 14673000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "financials": {"balance_sheet": {"fixed_assets": {"value": 7113000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "inventory": {"value": 7039000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 353977000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 334715000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": -19262000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 323800000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 10915000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 105654000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 308518000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_liabilities": {"value": 248323000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 334715000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 3802000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": -19262000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "wages": {"value": 11030000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 18713000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "accounts_receivable": {"value": 8243000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_current_liabilities": {"value": 75911000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -60493000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -60493000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 198868000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 175643000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 21414000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -44639000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 175643000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 198868000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -44639000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 21414000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -60493000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": 4016000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -60493000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "selling_general_and_administrative_expenses": {"value": 20986000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_parent": {"value": -60493000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 56388000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 3140000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "gross_profit": {"value": 3983000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "other_operating_expenses": {"value": 48000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "cost_of_revenue": {"value": 33000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_income_loss": {"value": -52405000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -60493000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_expense_operating": {"value": 5609000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "research_and_development": {"value": 35354000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 4016000.0, "unit": "USD", "label": "Revenues", "order": 100}}}}]